AMFPF
Price
$23.85
Change
+$1.83 (+8.31%)
Updated
Jun 4 closing price
Capitalization
8.23B
COR
Price
$296.23
Change
+$5.06 (+1.74%)
Updated
Jul 3 closing price
Capitalization
48.42B
31 days until earnings call
Interact to see
Advertisement

AMFPF vs COR

Header iconAMFPF vs COR Comparison
Open Charts AMFPF vs CORBanner chart's image
Amplifon S.p.A
Price$23.85
Change+$1.83 (+8.31%)
Volume$500
Capitalization8.23B
Cencora
Price$296.23
Change+$5.06 (+1.74%)
Volume$614.99K
Capitalization48.42B
AMFPF vs COR Comparison Chart in %
Loading...
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMFPF vs. COR commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and COR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (AMFPF: $23.85 vs. COR: $296.23)
Brand notoriety: AMFPF and COR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 31% vs. COR: 40%
Market capitalization -- AMFPF: $8.23B vs. COR: $48.42B
AMFPF [@Medical Distributors] is valued at $8.23B. COR’s [@Medical Distributors] market capitalization is $48.42B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 0 FA rating(s) are green whileCOR’s FA Score has 4 green FA rating(s).

  • AMFPF’s FA Score: 0 green, 5 red.
  • COR’s FA Score: 4 green, 1 red.
According to our system of comparison, COR is a better buy in the long-term than AMFPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 2 TA indicator(s) are bullish while COR’s TA Score has 4 bullish TA indicator(s).

  • AMFPF’s TA Score: 2 bullish, 1 bearish.
  • COR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, COR is a better buy in the short-term than AMFPF.

Price Growth

AMFPF (@Medical Distributors) experienced а 0.00% price change this week, while COR (@Medical Distributors) price change was -0.12% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.01%. For the same industry, the average monthly price growth was +7.79%, and the average quarterly price growth was -2.46%.

Reported Earning Dates

COR is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Distributors (+2.01% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($48.4B) has a higher market cap than AMFPF($8.23B). AMFPF has higher P/E ratio than COR: AMFPF (40.21) vs COR (26.47). COR YTD gains are higher at: 32.397 vs. AMFPF (-8.278). COR has higher annual earnings (EBITDA): 3.71B vs. AMFPF (520M). COR has more cash in the bank: 2.87B vs. AMFPF (198M). AMFPF has less debt than COR: AMFPF (1.58B) vs COR (4.78B). COR has higher revenues than AMFPF: COR (272B) vs AMFPF (2.22B).
AMFPFCORAMFPF / COR
Capitalization8.23B48.4B17%
EBITDA520M3.71B14%
Gain YTD-8.27832.397-26%
P/E Ratio40.2126.47152%
Revenue2.22B272B1%
Total Cash198M2.87B7%
Total Debt1.58B4.78B33%
FUNDAMENTALS RATINGS
AMFPF vs COR: Fundamental Ratings
AMFPF
COR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
962
SMR RATING
1..100
6012
PRICE GROWTH RATING
1..100
5926
P/E GROWTH RATING
1..100
8719
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMFPF's Valuation (37) in the null industry is somewhat better than the same rating for COR (90) in the Real Estate Investment Trusts industry. This means that AMFPF’s stock grew somewhat faster than COR’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is significantly better than the same rating for AMFPF (96) in the null industry. This means that COR’s stock grew significantly faster than AMFPF’s over the last 12 months.

COR's SMR Rating (12) in the Real Estate Investment Trusts industry is somewhat better than the same rating for AMFPF (60) in the null industry. This means that COR’s stock grew somewhat faster than AMFPF’s over the last 12 months.

COR's Price Growth Rating (26) in the Real Estate Investment Trusts industry is somewhat better than the same rating for AMFPF (59) in the null industry. This means that COR’s stock grew somewhat faster than AMFPF’s over the last 12 months.

COR's P/E Growth Rating (19) in the Real Estate Investment Trusts industry is significantly better than the same rating for AMFPF (87) in the null industry. This means that COR’s stock grew significantly faster than AMFPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFCOR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
10%
Bearish Trend 4 days ago
49%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
48%
MACD
ODDS (%)
Bearish Trend 4 days ago
28%
Bearish Trend 4 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
28%
Bearish Trend 4 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
28%
Bullish Trend 4 days ago
63%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
61%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
41%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
63%
Aroon
ODDS (%)
Bullish Trend 4 days ago
13%
Bullish Trend 4 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPUU160.172.52
+1.60%
Direxion Daily S&P 500® Bull 2X ETF
ITAN32.940.25
+0.76%
Sparkline Intangible Value ETF
RGEF27.850.20
+0.73%
Rockefeller Global Equity ETF
RDVY63.780.31
+0.49%
First Trust Rising Dividend Achiev ETF
NXP14.01-0.06
-0.39%
Nuveen Select Tax-Free

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and COR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and COR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
COR - AMFPF
24%
Poorly correlated
+1.74%
ZYXI - AMFPF
7%
Poorly correlated
-10.78%
NSVGF - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
ARRJF - AMFPF
-0%
Poorly correlated
N/A
More

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
+1.74%
MCK - COR
65%
Loosely correlated
+1.96%
CAH - COR
61%
Loosely correlated
+1.82%
AMFPF - COR
24%
Poorly correlated
N/A
OMI - COR
21%
Poorly correlated
-0.86%
ZYXI - COR
7%
Poorly correlated
-10.78%
More